Summary
The antianginal activities of nicorandil, 10 and 20 mg bid, and metoprolol, 100 mg bid, were compared in patients with stable effort angina pectoris in a randomized, double-blind parallel group study lasting 7 weeks. Twenty patients were enrolled into the trial and 16 patients completed the study. To evaluate the antiischemic effects of the two drugs, a treadmill exercise test was performed after a 1-week placebo run-in period and 6 weeks of treatment. On the same occasions, weekly sublingual nitroglycerine consumption and the number of anginal attacks were also recorded in the patient's diary. The total duration of exercise increased significantly with both nicorandil, 10 and 20 mg, and metoprolol (p<0.01). Similar improvements were observed in the time to onset of ischemia with both treatments (p<0.01). The double product at maximal comparable workload (MAX 1) was reduced with the two drugs (p<0.05 for nicorandil and p<0.01 for metoprolol), while at the maximal exercise time (MAX 2) it was reduced with metoprolol (p<0.01) and slightly but not significantly increased with both doses of nicorandil. Weekly sublingual nitroglycerine consumption and anginal attacks were also significantly reduced a similar manner by both treatments (p<0.01). In conclusion, nicorandil, 10 and 20 mg bid, exerted an antiischemic effect comparable with that of metoprolol in patients with stable effort angina pectoris.
Similar content being viewed by others
References
Taira N, Satoh K, Yanagisawa T, et al. Pharmacological profile of a new coronary vasodilator drug 2-nicotin-amidethyl nitrate (SG-75).Clin Exp Pharmacol Physiol 1979;6:301–316.
Nakaya H, Kanda K, Oyama Y, et al. Pharmacokinetics and hemodynamic effects of SG-75 (2-nicotinamide ethyl nitrate).Jpn J Clin Pharmacol 1979;10:116–118.
Nakagawa Y, Takeda K, Katano Y, et al. Effects of 2-nicotinamidoethyl nitrate on the cardiovascular system.Jpn Heart J 1979;20:881–895.
Coltart DJ, Signy M. Acute hemodynamic effects of single dose nicorandil in patients with ischaemic heart disease.Am J Cardiol 1989;63:34J-39J.
Uchida Y, Yoshimoto N, Murao S. Effects of SG-75 on coronary circulation.Jpn Heart J 1978;19:112–124.
Sakai K, Shirai Y, Nabata H. Cardiovascular effects of a new coronary vasodilator n-(2-hydroxy ethyl) nicotinamide nitrate (SG-75): comparison with nitroglycerin and diltiazem.J Cardiovasc Pharmacol 1981;3:139–150.
Suryapranata H, Serruys PW, De Feyter PJ, et al. Coronary vasodilatory actions after a single dose of nicorandil.Am J Cardiol 1988;61:292–297.
Belz GG, Matthews J, Heinrich J, et al. Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man.Eur J Clin Pharmacol 1984;26:681–685.
Belz GG, Matthews JH, Beck A, et al. Hemodynamic effect of nicorandil, isosorbide dinitrate, and dehydralazine in healthy volunteers.J Cardiovasc Pharmacol 1985;7:1107–1112.
Holzmann S. Cyclic GMP as possible mediator of coronary arterial relation by nicorandil (SG-75).J Cardiovasc Pharmacol 1983;5:364–370.
Imanishi S, Arita M, Kiyosue T, et al. Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance.J Pharmacol Exp Ther 1983;225:198–205.
Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators.Am J Cardiol 1989;63:18J-24J.
Hayata N, Araki H, Nakamura M. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.Am Heart J 1986;112:1245–1250.
Kato K, Asanoi H, Wakabayashi C, et al. Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test.J Cardiovasc Pharmacol 1987;10(Suppl. 8):S98-S103.
Camm AJ, Maltz MB. A controlled single dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.Am J Cardiol 1989;63:61J-65J.
Meany TB, Richardson P, Camm AJ, et al. Exercise capacity after single and twice daily doses of nicorandil in chronic stable angina pectoris.Am J Cardiol 1989;63:66J-70J.
Kobayashi K, Hakuta T. Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerine nifedipine, and propranolol.J Cardiovasc Pharmacol 1987;10(Suppl. 8):S109-S115.
Kinoshita M, Hashimoto K, Ohbayashi Y, et al. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.Am J Cardiol 1989;63:71J-74J.
Brogden RN, Heel RC, Speight TM, et al. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.Drugs 1987;14:321–348.
Hammershoy O. A Nordic multicentre dose response study of metoprolol in angina pectoris patients.Curr Ther Res 1982;31:1026–1034.
Kinoshita M, Nishikawa S, Sawamura M, et al. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris.Am J Cardiol 1986;58:733–738.
Thormann J, Schlepper M, Kramer W, et al. Effectiveness of nicorandil (SG-75), a new long acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.J Cardiovasc Pharmacol 1983;5:371–377.
Aizawa T, Ogasawara K, Kato K. Effects of nicorandil on coronary circulation in patients with ischaemic heart disease: comparison with nitroglycerin.J Cardiovasc Pharmacol 1987;10(Suppl. 8):S123-S129.
Silke B, Verma SP, Ali MS, et al. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.Am J Cardiol 1989;63:49J-55J.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Somma, S., Liguori, V., Petitto, M. et al. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Cardiovasc Drug Ther 7, 119–123 (1993). https://doi.org/10.1007/BF00878320
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00878320